{
    "organizations": [],
    "uuid": "d8e0136addbb365f6c0a469c9a73d83033b2c377",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tianjin-tianyao-pharmaceuticals-si/brief-tianjin-tianyao-pharmaceuticals-signs-two-api-technical-development-commission-contracts-worth-3-mln-yuan-idUSL4N1Q42SJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Tianjin Tianyao Pharmaceuticals signs two API technical development commission contracts worth 3 mln yuan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Tianjin Tianyao Pharmaceuticals Co Ltd :\n* Says it and Tianjin Pharmaceuticals Research Institute Co., Ltd signs two technical development commission contracts of API glycyl-glutamine and glycyltyrosine worth 3 million yuan\nSource text in Chinese: goo.gl/WMG4QE\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-14T14:21:00.000+02:00",
    "crawled": "2018-02-15T20:46:28.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "tianjin",
        "tianyao",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "tianjin",
        "pharmaceutical",
        "research",
        "institute",
        "ltd",
        "sign",
        "two",
        "technical",
        "development",
        "commission",
        "contract",
        "api",
        "glycyltyrosine",
        "worth",
        "million",
        "yuan",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}